参考文献/References:
[1] 汪汉, 蔡琳. 心功能与类风湿关节炎[J]. 心血管病学进展,2013, 34(5):690-694.
[2] 汪汉,蔡琳. 多发性肌炎/皮肌炎的心脏病变[J]. 心血管病学进展,2015, 36(3):332-337.
[3] Lai YT, Dai YS, Yen MF, et al. Dermatomyositis is associated with an increased risk of cardiovascular and cerebrovascular events:a Taiwanese population-based longitudinal follow-up study[J]. Br J Dermatol, 2013, 168(5):1054-1059.
[4] 陆再英, 钟南山. 内科学[M]. 第7版.北京:人民卫生出版社,2007.
[5] Eisen A, Arnson Y, Dovrish Z, et al. Arrhythmias and conduction defects in rheumatological diseases—a comprehensive review[J]. Semin Arthritis Rheum, 2009, 39(3):145-156.
[6] Lazzerini PE, Capecchi PL, Guideri F, et al. Connective tissue diseases and cardiac rhythm disorders: an overview[J]. Autoimmun Rev, 2006,5(5):306-313.
[7] Lacroix D, Brigadeau F, Marquié C, et al. Electroanatomic mapping and ablation of ventricular tachycardia associated with systemic sclerosis[J]. Europace,2004, 6(4):336-342.
[8] Chung HH, Kim JB, Hong SH, et al. Radiofrequency catheter ablation of hemodynamically unstable ventricular tachycardia associated with systemic sclerosis[J]. J Korean Med Sci, 2012,27(2):215-217.
[9] Yazdi HR, Rostami N, Hakimian H, et al. Successful catheter-directed venous thrombolysis in an ankylosing spondylitis patient with phlegmasia cerulea dolens[J]. Iran J Radiol, 2013,10(2): 81-85.
[10] Maradit-Kremers H, Crowson CS, Nicola PJ, et al. Increased unrecognized coronary heart disease and sudden deaths in rheumatoid arthritis:a population-based cohort study[J]. Arthritis Rheum, 2005,52(2):402-411.
[11] Arce-Salinas CA, Carmona-Escamilla MA, Rodriguez-Garcia F. Complete atrioventricular block as initial manifestation of systemic lupus erythematosus[J]. Clin Exp Rheumatol, 2009,27(2):344-346.
[12] Gomez-Barrado JJ, Garcia-Rubira JC, Polo Ostariz MA, et al. Complete atrioventricular block in a woman with systemic lupus erythematosus[J]. Int J Cardiol, 2002, 82(3):289-292.
[13] Comin-Colet J, Sanchez-Corral MA, Alegre-Sancho JJ, et al. Complete heart block in an adult with systemic lupus erythematosus and recent onset of hydroxychloroquine therapy[J]. Lupus, 2001,10(1):59-62.
[14] Gonzales Lopez L, Gamez-Nava JI, Sanchez L, et al. Cardiac manifestations in dermato-polymyositis[J]. Clin Exp Rheumatol, 1996,14(4):373-379.
[15] Gottdiener JS, Sherber HS, Hawley RJ, et al. Cardiac manifestations in polymyositis[J]. Am J Cardiol, 1978,41(7):1141-1149.
[16] Ozgül M, Hocan Y, Arslan C, et al. Complete atrioventricular block in a patient with rheumatoid arthritis[J]. Turk Kardiyol Dern Ars, 2008,36(4):263-265.
[17] Moyssakis I, Papadopoulos DP, Tzioufas AG, et al. Complete heart block in a patient with systemic sclerosis[J]. Clin Rheumatol, 2006,25(4):551-552.
[18] Canpolat U, Canpolat AG, Kabakci G. Complete heart block and permanent pacemaker implantation in a patient with systemic sclerosis[J]. Anadolu Kardiyol Derg, 2012, 12(7):609-610.
[19] Oe K, Mori K, Gommori S, et al. Syncope due to paroxysmal atrioventricular block in a patient with systemic sclerosis:a case report[J]. Angiology, 2008,59(6):769-771.
[20] Hagen A, Albig M, Schmitz L, et al. Intrauterine treatment of incomplete fetal heart block in a mother with Sjogren syndrome[J]. Ultraschall Med, 2008,29(Suppl 5N): 268-270.
[21] Adhiyaman V, Oke A, Aziz K, et al. Progressive heart block in active rheumatoid arthritis[J]. Int J Clin Pract, 2000,54(8):544-545.
[22] Kang JH, Keller JJ, Lin HC. Outcomes of nonstenting percutaneous coronary intervention in patients with rheumatoid arthritis[J]. Am J Cardiol, 2012,109(8):1160-1163.
[23] Desai SP, Januzzi JL, Pande AN, et al. Comparison of symptoms, treatment, and outcomes of coronary artery disease among rheumatoid arthritis and matched subjects undergoing percutaneous coronary intervention[J]. Semin Arthritis Rheum, 2010, 40(3):215-221.
[24] Komooka M, Higashiue S, Matsubayashi K, et al. Vascular Behcet disease presenting large right coronary artery pseudoaneurysm after percutaneous coronary intervention(PCI):report of a case[J]. Kyobu Geka, 2013,66(9):845-848.
[25] Nakajima A, Yoshida K, Utsunomiya T, et al. Behcet disease with exacerbation in summer and late coronary stent occlusion[J]. Nihon Naika Gakkai Zasshi, 2004, 93(5):1003-1005.
[26] Park JH, Chung JW, Joh JH, et al. Aortic and arterial aneurysms in Behcet disease: management with stent-graft—initial experience[J]. Radiology, 2001,220(3):745-750.
[27] Sharma BK, Jain S, Bali HK, et al. A follow-up study of balloon angioplasty and de-novo stenting in Takayasu arteritis[J]. Int J Cardiol, 2000,75(Suppl 1N):S147-S152.
[28] Chapdelaine JP, Najarian KE,D'Agostino R, et al. Stent placement in a carotid artery bypass graft in a patient with Takayasu arteritis[J]. J Vasc Interv Radiol, 1998, 9(5):846-848.
[29] Tyagi S, Verma PK, Kumar N, et al. Stent angioplasty for relief of chronic mesenteric ischemia in Takayasu arteritis[J]. Indian Heart J, 1997,49(3):315-318.
[30] Yokota K, Shimpo M, Iwata T, et al. A case of Takayasu arteritis with repeated coronary artery restenosis after drug-eluting stent implantation successfully treated with a combination of steroids[J]. Intern Med, 2012,51(7):739-743.
[31] Mehta PK, Samady H, Vassiliades TA, et al. Acute coronary syndrome as a first presentation of systemic lupus erythematosus in a teenager: revascularization by hybrid coronary artery bypass graft surgery and percutaneous coronary intervention: case report[J]. Pediatr Cardiol, 2008,29(5):957-961.
[32] Aldoboni AH, Hamza EA, Majdi K, et al. Spontaneous dissection of coronary artery treated by primary stenting as the first presentation of systemic lupus erythematosus[J]. J Invasive Cardiol, 2002,14(11):694-696.
[33] Lee CH, Chan MY. Dilemma of drug-eluting stent implantation in a patient with systemic lupus erythematosus[J]. Int J Cardiol, 2007,114(3):e107-e108.
[34] Lee CH, Chong E, Low A, et al. Long-term follow-up after percutaneous coronary intervention in patients with systemic lupus erythematosus[J]. Int J Cardiol,2008, 126(3):430-432.